Not exact matches
This clinical trial is the culmination of long - standing research led by Professor John Greenwood at the UCL Institute of Ophthalmology showing the potential therapeutic benefits of using statins to treat
autoimmune diseases such as multiple sclerosis and
uveitis.
«We tested this approach on the
uveitis model as a proof of principle, but it should also be applicable to other
autoimmune conditions,» says co-senior author Dr Richard Jenner (UCL Cancer Institute).
The study, published in Cell Reports, involved giving cancer drugs to mice and inducing
uveitis, an incurable
autoimmune eye condition responsible for 1 in every 10 cases of visual impairment in the UK.
Fourth, there is theoretical potential for inducing
autoimmune disease such as
uveitis and, lastly, there is incomplete knowledge of mechanisms of protective immunity against leptospiral infection.»